Sunshine Biopharma (SBFM) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Sunshine Biopharma (SBFM) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 4.64 Mn |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn | 4.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04 Mn |
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | 5.48 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 5.13 Mn |
| Sep 30, 2024 | 3.97 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 24.85 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 771,420.00 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 303,460.00 |
| Sep 30, 2021 | 527,129.00 |